Joep Muijrers joined Gilde in 2021 with two decades of broad experience in life sciences, including senior roles in portfolio management, company operations and investment banking. Most recently, he served as Chief Financial Officer and Chief of Portfolio Strategy at PureTech Health (PRTC), a Boston-based biotech company focused on developing highly differentiated medicines for devastating diseases.
Prior to PureTech, Joep worked for ten years as a Portfolio Manager at LSP, where he invested in publicly-traded life sciences companies. Prior to joining LSP, Joep served as Director Corporate Finance and Capital Markets at Fortis Bank, where he focused on financing and M&A transactions for life sciences companies in Europe and the US.
Joep holds a Ph.D. degree in Molecular Biology from the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, and a Master’s degree in Biochemistry from the University of Nijmegen.
Joep has served on the Board of Directors of seven healthcare companies and as an advisor to two not-for-profit entities. Joep is actively engaged in multi-stakeholder interaction and has been an invited speaker at events organized by the European Medicines Agency, DIA, NICE, ISPOR, BioCentury, BIO and other organizations.
At Gilde Healthcare he focuses on publicly traded companies that can deliver better care at lower cost.
Pieter van der Meer